1181P The impact of dosimetric parameters on pneumonitis in patients with stage III non-small cell lung cancer during maintenance treatment with durvalumab after chemoradiotherapy
| Autor: | Vrankar, M., But-Hadzic, J., Stanic, K., Ciric, E., Jelercic, S., Vodusek, A.L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S944-S944 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|